William Flanary, MD, an ophthalmologist better known as Dr. Glaucomflecken, stirred online debates among physicians after his ...
The FDA approved ropeginterferon alfa-2b (Besremi) injection to treat adults with essential thrombocythemia, the first new ...
Infectious disease specialists are sounding the alarm about a Trump administration plan to eliminate a clinical research unit ...
A judge declared a mistrial in the Lindsay Clancy murder trial on Friday after jurors said they could not reach a unanimous ...
Valmed in diagnosing rheumatologic conditions. Use of Prof. Valmed did not improve diagnostic accuracy but reduced the time ...
From 1990 to 2023, alcohol-attributable cancer deaths doubled from 11,361 (age-standardized mortality rate [ASMR] 3.8 per 100 ...
It makes sense for optometrists to monitor patients with wet AMD for signs of worsening, Dunbar said, especially in light of ...
GLP-1 receptor agonists may be powerful tools for treating obesity and cardiometabolic disease, but relying on medications ...
There's actually a new opioid-free drug that's called suzetrigine [Journavx], which was recently approved by the Food and ...
It's been almost a month since Sen. Mitch McConnell (R-Ky.) last shared a health update, leading to another round of ...
The FDA warned that Boston Scientific's recalled spinal cord stimulator for chronic limb pain has been linked to 1,081 ...
Prescriptions for GLP-1 drugs surged 310-fold (from 0.03% to 9.3%) among kids ages 8 to 11 with obesity, despite a lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results